Pixium Vision announces its cash position at 31 March 2021 and provides an update on its activities and financial outlook until the end of 2021.
April 18, 2021 13:00 ET
|
Pixium Vision
Pixium Vision announces its cash position at 31 March 2021 and provides an update on its activities and financial outlook until the end of 2021. Paris, 16 April 2021 – 6:00 p.m. CEST - Pixium Vision...
AMD to Report Fiscal First Quarter 2021 Financial Results
April 15, 2021 16:15 ET
|
Advanced Micro Devices, Inc.
SANTA CLARA, Calif., April 15, 2021 (GLOBE NEWSWIRE) -- AMD (NASDAQ: AMD) announced today that it will report first quarter 2021 financial results on Tuesday, April 27, 2021 after the close of...
AMD and Xilinx Stockholders Overwhelmingly Approve AMD’s Acquisition of Xilinx
April 07, 2021 12:49 ET
|
Advanced Micro Devices, Inc.
SILICON VALLEY, Calif., April 07, 2021 (GLOBE NEWSWIRE) -- AMD (NASDAQ:AMD) and Xilinx, Inc. (NASDAQ:XLNX) announced today that stockholders voted to approve their respective proposals relating to...
Pixium Vision annonce l’implantation réussie du premier patient de l’étude pivot PRIMAvera du Système Prima
April 07, 2021 01:00 ET
|
Pixium Vision
Pixium Vision annonce l’implantation réussie du premier patient de l’étude pivot PRIMAvera du Système Prima Cette étude est la dernière étape clinique avant la demande d’autorisation de mise sur le...
Pixium Vision announces first patient successful implantation in Prima System pivotal trial PRIMAvera
April 07, 2021 01:00 ET
|
Pixium Vision
Pixium Vision announces first patient successful implantation in Prima System pivotal trial PRIMAvera Study is the last clinical step before seeking market approval in Europe in dry AMDBionic vision...
ForeseeHome AMD home monitoring real-world data analysis demonstrates substantial benefit for patients’ vision
April 06, 2021 08:00 ET
|
Notal Vision
Manassas, VA, April 06, 2021 (GLOBE NEWSWIRE) -- Real-world data on the performance of the ForeseeHome® AMD Monitoring Program, a home-based diagnostic that helps detect the conversion from...
Termination of the business combination with Second Sight Medical Products, Inc.
April 02, 2021 19:30 ET
|
Pixium Vision
Termination of the business combination with Second Sight Medical Products, Inc. Paris, France, April 3, 2021 – Considering the private placement recently announced and closed by Second Sight Medical...
Pixium Vision announces new compelling results with Prima System demonstrating integration of prosthetic and natural vision
March 30, 2021 01:00 ET
|
Pixium Vision
Data mark a major step forward in treatment of atrophic AMD Results confirm the safety and stability of the Prima System implant over 24-30 months follow-upPrima System pivotal PRIMAvera study ongoing...
Pixium Vision prend acte des termes du communiqué de presse publié par Second Sight Medical Products, Inc. Paris, France, le 24 mars 2021 - Pixium Vision (Euronext Growth Paris - FR0011950641) (« Pixium ») prend acte des termes du commun
March 24, 2021 20:00 ET
|
Pixium Vision
Acknowledgment of the terms of the press release issued by Second Sight Medical Products, Inc. Paris, France, March 24, 2021 – Pixium Vision (Euronext Growth Paris - FR0011950641) (“Pixium”)...
Poursuite du projet de rapprochement entre Pixium Vision et Second Sight Medical Products Inc.
March 09, 2021 03:00 ET
|
Pixium Vision
Poursuite du projet de rapprochement entre Pixium Vision et Second Sight Medical Products Inc. Paris, France, le 9 mars 2021 8h30 – Pixium Vision (Euronext Growth Paris - FR0011950641) indique...